Preventing Diabetes.

Sigrid Therapeutics® is recruiting patients for our clinical trial STAR

Interested in participating?
A Little Of Our Story

Our Medical Device: SiPore15TM

SiPore15™ is a breakthrough medical device for the safe reduction of blood sugar levels in people at risk of developing diabetes, prediabetics, and newly diagnosed type 2 diabetics. The device is a tasteless and odourless white powder taken with water. Upon its approval, SiPore15™ will be the first non-systemic therapy for prediabetes, with the potential to prevent type 2 diabetes.

SiPore15™ is Sigrid Therapeutics’ lead product candidate in clinical development, originating from research at Stockholm University and Karolinska Institutet.

Learn more
A Little Of Our Story

About Us

Lifestyle diseases, caused by poor diet and physical inactivity among others, are rising rapidly worldwide. Each year, 70% of all deaths globally – 40 million – are attributed to lifestyle diseases such as obesity, type 2 diabetes and heart disease.

Sigrid is a clinical-stage biotech Company driven by the vision to improve human health through material based innovations. We are pioneering a new class of engineered materials to prevent and treat lifestyle disease more safely than existing solutions on the market.

Learn more
A Little Of Our Story

Clinical Trials

We are currently recruiting patients for our clinical trial STAR of our lead product candidate SiPore15™ for improvement in blood sugar levels in prediabetics and newly diagnosed type 2 diabetics.

Learn more

All Disease Begins in the Gut

HippocratesThe Father of Medicine

RESEARCH COLLABORATIONS